FindTrial
Sign In

To compare neurocognitive function changes before and after treatment in brain metastases patients undergoing External beam Radiation therapy.

A prospective study comparing neurocognitive function changes in patients with brain metastases - pre v/s post radiation therapy. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/082867
Enrollment
30
Registered
2025-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C793- Secondary malignant neoplasm of brain and cerebral meninges

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Muskan Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age greater than 18 years and less than 75 years Radiologically proven brain metastatic lesions secondary to any primary cancer Recurrence of Brain Metastases in already treated patient Eastern clinical oncology group performance status ECOG less than or equal to 2

Exclusion criteria

Exclusion criteria: Primary Brain tumour patients

Design outcomes

Primary

MeasureTime frame
To evaluate the scores of ACE-III Neurocognitive function test in Brain metastases patients before undergoing Radiation therapy treatment v/s 3 months after completion of External Beam Radiation therapy treatment.Timepoint: To evaluate the scores of ACE-III Neurocognitive function test in Brain metastases patients before undergoing Radiation therapy treatment v/s 3 months after completion of External Beam Radiation therapy treatment.—

Secondary

MeasureTime frame
To evaluate the scores of ACE-III Neurocognitive function test in Brain metastases patients before & after undergoing Whole brain Radiotherapy (WBRT) treatment v/s before & after undergoing Stereotactic Radiation therapy (SRT) treatment.Timepoint: At Baseline , after 3 months of treatment—

Countries

India

Contacts

Public ContactDr Rashi Agrawal

Max Super Specialty Hospital

drrashi.ag@gmail.com9891483550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026